Muhlenkamp & CO Inc Pfizer Inc Transaction History

Muhlenkamp & CO Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $10,003 - $11,861	-215 Reduced 0.88%	24,164 $1.27 Million
Q1 2021 Aug 18, 2021	BUY	$33.49 - $37.77 $21,433 - $24,172	640 Added 2.7%	24,379 $1.23 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $937 - $1,191	-28 Reduced 0.12%	23,739 $874,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $4,921 - $5,773	-155 Reduced 0.65%	23,767 $872,000
Q2 2020 Aug 20, 2020	SELL	$30.12 - $36.54 $32,891 - $39,901	-1,092 Reduced 4.37%	23,922 $782,000
Q4 2019 Feb 20, 2020	SELL	$32.92 - $37.36 $22,221 - $25,218	-675 Reduced 2.63%	25,014 $980,000
Q3 2019 Nov 27, 2019	SELL	$32.49 - $42.13 $3,119 - $4,044	-96 Reduced 0.37%	25,689 $923,000
Q2 2019 Aug 28, 2019	BUY	$36.98 - $41.52 $3,697 - $4,152	100 Added 0.39%	25,785 $1.12 Million
Q1 2019 May 23, 2019	SELL	$37.5 - $41.2 $27,937 - $30,694	-745 Reduced 2.82%	25,685 $1.09 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $36,365 - $44,109	-1,055 Reduced 3.84%	26,430 $1.17 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $8,113 - $8,649	246 Added 0.9%	27,485 $997,000
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $8,137 - $9,440	-255 Reduced 0.93%	27,239 $0
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $171,740 - $189,191	-5,540 Reduced 16.77%	27,494 $982,000
Q2 2017 Aug 11, 2017	BUY	N/A	33,034	33,034 $1.11 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Muhlenkamp & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Muhlenkamp & CO Inc with notifications on news.